Erasmus Schneider

2.5k total citations
42 papers, 1.8k citations indexed

About

Erasmus Schneider is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Erasmus Schneider has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Oncology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Erasmus Schneider's work include Drug Transport and Resistance Mechanisms (15 papers), Cancer therapeutics and mechanisms (12 papers) and DNA Repair Mechanisms (7 papers). Erasmus Schneider is often cited by papers focused on Drug Transport and Resistance Mechanisms (15 papers), Cancer therapeutics and mechanisms (12 papers) and DNA Repair Mechanisms (7 papers). Erasmus Schneider collaborates with scholars based in United States, Switzerland and New Zealand. Erasmus Schneider's co-authors include Erin L. Volk, Y H Hsiang, Leroy F. Liu, James Chih‐Hsin Yang, Kenneth H. Cowan, Robert W. Robey, Fei Li, Yan Wu, Thomas J. Ryan and Alan J. Townsend and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Erasmus Schneider

42 papers receiving 1.8k citations

Peers

Erasmus Schneider
E Schneider United States
Yoji Ikegami Japan
Shin‐ichi Akiyama Japan
W N Hait United States
Robert L. Shepard United States
Elizabeth Hopper-Borge United States
Shin-ichi Akiyama Japan
Orsolya Polgár United States
Gregory Tombline United States
Marilyn M. Cornwell United States
E Schneider United States
Erasmus Schneider
Citations per year, relative to Erasmus Schneider Erasmus Schneider (= 1×) peers E Schneider

Countries citing papers authored by Erasmus Schneider

Since Specialization
Citations

This map shows the geographic impact of Erasmus Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erasmus Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erasmus Schneider more than expected).

Fields of papers citing papers by Erasmus Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erasmus Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erasmus Schneider. The network helps show where Erasmus Schneider may publish in the future.

Co-authorship network of co-authors of Erasmus Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Erasmus Schneider. A scholar is included among the top collaborators of Erasmus Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erasmus Schneider. Erasmus Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Meiling, Xiaolong He, Pui Lai Rachel Ee, et al.. (2011). Notch1 regulates the expression of the multidrug resistance geneABCC1/MRP1in cultured cancer cells. Proceedings of the National Academy of Sciences. 108(51). 20778–20783. 87 indexed citations
2.
Schneider, Erasmus & Gerald J. Mizejewski. (2007). Multi-marker testing for cancer: what can we learn from modern prenatal testing for Trisomy-21. SHILAP Revista de lepidopterología. 1 indexed citations
3.
Shao, Yu, et al.. (2007). A structural analysis of in vitro catalytic activities of hammerhead ribozymes. BMC Bioinformatics. 8(1). 469–469. 9 indexed citations
4.
Schneider, Erasmus & Gerald J. Mizejewski. (2006). Multi-Marker Testing for Cancer: What can we Learn from Modern Prenatal Testing for Trisomy-21. Cancer Informatics. 2. 2816755208–2816755208. 2 indexed citations
5.
Schneider, Erasmus & Thomas J. Ryan. (2006). Gamma-glutamyl hydrolase and drug resistance. Clinica Chimica Acta. 374(1-2). 25–32. 50 indexed citations
6.
Marshall, Lisa A., Myung S. Rhee, Lars Hofmann, Alexey Khodjakov, & Erasmus Schneider. (2005). Increased lysosomal uptake of methotrexate-polyglutamates in two methotrexate-resistant cell lines with distinct mechanisms of resistance. Biochemical Pharmacology. 71(1-2). 203–213. 10 indexed citations
7.
8.
9.
Murphy, Robert C., Erasmus Schneider, & Kathleen W. Kinnally. (2001). Overexpression of Bcl‐2 suppresses the calcium activation of a mitochondrial megachannel. FEBS Letters. 497(2-3). 73–76. 44 indexed citations
10.
Yang, James Chih‐Hsin, et al.. (2000). BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells. Biochemical Pharmacology. 60(6). 831–837. 99 indexed citations
11.
Sánchez‐Alcázar, José A., Erasmus Schneider, Miguel Ángel Martı́nez, et al.. (2000). Tumor Necrosis Factor-α Increases the Steady-state Reduction of Cytochrome b of the Mitochondrial Respiratory Chain in Metabolically Inhibited L929 Cells. Journal of Biological Chemistry. 275(18). 13353–13361. 79 indexed citations
12.
Morrow, Charles S., et al.. (1998). Coordinated Action of Glutathione S-Transferases (GSTs) and Multidrug Resistance Protein 1 (MRP1) in Antineoplastic Drug Detoxification. Journal of Biological Chemistry. 273(32). 20114–20120. 118 indexed citations
13.
Pérez-Soler, Román, Nouri Neamati, Yiyu Zou, et al.. (1997). Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide. International Journal of Cancer. 71(1). 35–41. 15 indexed citations
14.
Sinha, Birandra K., Hiroyuki Yamazaki, Helen M. Eliot, et al.. (1995). Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1270(1). 12–18. 46 indexed citations
15.
Соколова, И. А., Kenneth H. Cowan, & Erasmus Schneider. (1995). Ca2+/Mg2+-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1266(2). 135–142. 32 indexed citations
16.
Schneider, Erasmus, Y H Hsiang, & Leroy F. Liu. (1990). DNA Topoisomerases as Anticancer Drug Targets. Advances in pharmacology. 21. 149–183. 183 indexed citations
17.
Schneider, Erasmus, et al.. (1988). Relationship between sensitivity to 4′-(9-acridinylamino)methanesulfon-m-anisidide and DNA topoisomerase II in a cold-sensitive cell-cycle mutant of a murine mastocytoma cell line. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 951(1). 85–97. 5 indexed citations
18.
Schneider, Erasmus, et al.. (1988). Mechanism of resistance of non-cycling mammalian cells to 4′-[9-acridinylamino]methanesulphon-m-anisidide: Role of DNA topoisomerase II in log- and plateau-phase CHO cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 949(3). 264–272. 24 indexed citations
19.
Schneider, Erasmus, et al.. (1988). Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II. European Journal of Cancer and Clinical Oncology. 24(11). 1783–1790. 55 indexed citations
20.
Michel, H, et al.. (1981). Intrinsic membrane proteins of the thylakoids of Chlamydomonas reinhardii. Photosynthesis Research. 2(3). 203–212. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Schneider Breakdown of academic impact, for papers by Yoji Ikegami Breakdown of academic impact, for papers by Shin‐ichi Akiyama Breakdown of academic impact, for papers by W N Hait Breakdown of academic impact, for papers by Robert L. Shepard Breakdown of academic impact, for papers by Elizabeth Hopper-Borge Breakdown of academic impact, for papers by Shin-ichi Akiyama Breakdown of academic impact, for papers by Orsolya Polgár Breakdown of academic impact, for papers by Gregory Tombline Breakdown of academic impact, for papers by Marilyn M. Cornwell
Rankless by CCL
2026